Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

We recently compiled a list of the 10 Best Low Risk Stocks To Buy in 2025. In this article, we are going to take a look at ...

GE Aerospace is the latest company to announce an investment in the U.S. economy under the Trump administration. GE said the ...

U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide. “We feel that a product like an oral, orforglipron, could serve a significant ...

Like many pharma stocks, Eli Lilly ... pill form. And Lilly may even submit orforglipron for regulatory approval as early as this year. If Lilly is able to commercialize a new weight loss product ...

The weight loss drug segment is still quite new, and there will be many fits and starts by developers. Zeroing in on Eli Lilly, the company is already well established with Zepbound, which should ...

Eli Lilly stock ... in pill form. And Lilly may even submit orforglipron for regulatory approval as early as this year. If Lilly is able to commercialize a new weight loss product in the next ...

Shares of Novo Nordisk (NVO) are sliding in Monday trading after the company announces results for its trial of weight-loss drug CagriSema.